Oxford Immunotec Global PLC announced the appointment of Karen Koski as Head of Strategy and Investor Relations. The newly created position will report directly to Oxford Immunotec's Chief Executive Officer, Dr. Peter Wrighton-Smith. Ms. Koski will join the company on June 21, 2017. Ms. Koski joins the company with a wealth of knowledge and experience in the diagnostics industry. Most recently, Ms. Koski served as a Director and Senior Equity Analyst at BTIG, LLC where she covered companies in the Medical Technology, Life Sciences, and Diagnostics sectors.